Galderma Receives FDA Approval For Restylane® Kysse | 合法醫療器材資訊網

2020年5月6日—RestylaneKysseisanewlipfillerthatofferskeyattributesboth ...

Lausanne, Switzerland, May 6 - Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Kysse for lip augmentation and the correction of upper perioral rhytids (wrinkles around upper lips) in adults over the age of 21.1 Restylane Kysse is the first hyaluronic acid (HA) filler specifically indicated for the lips using XpresHAn Technology™ (pronounced ex-ˈspre-shan) globally referred to as the OBT technology (Optimal Balance Technology). Restylane Kysse is proven to last for up to 1 year1,2 with high levels of patient satisfaction for people with lips that have changed due to the aging process or for those seeking natural-looking, fuller lips.3

"Restylane Kysse is a new lip filler that offers key attributes both providers and their patients desire in a lip injection –  high satisfaction, consistent results, and a proven clinical-safety profile...